ACHILLES THERAPEUTICS PLC ACHL 深 滬
交易中 09-16 15:10:44 美东时间
0.7056
-0.017
-2.38%
華盛通- 最 高0.738
- 今 開0.738
- 成交量 1.88万股
- 最 低 0.7056
- 昨 收 0.7228
- 總市值 2877.64万
- 52周最高 1.76
- 市盈率 靜 --
- 換手率 0.05%
- 52周最低 0.63
- 委 比 47.92%
- 總股本 4078.29万
- 歷史最高 18.948
- 量 比 0.91
- 振 幅 4.48%
- 歷史最低 0.63
- 每 手 1
- 風險率 0.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Achilles Therapeutics Excels in Q2 with Promising Trials
Achilles Therapeutics (ACHL) has released an update. Achilles Therapeutics has ...
08-14 20:27
Leadership Shift at Achilles Therapeutics
Achilles Therapeutics (ACHL) has released an update. Achilles Therapeutics has ...
08-06 04:27
Achilles Therapeutics AGM Concludes with Key Approvals
Achilles Therapeutics (ACHL) has released an update. Achilles Therapeutics plc ...
06-28 04:27
快讯 | Achilles Therapeutics宣布与Arcturus Therapeutics进行研究合作，探索第二代个性化mrna癌症疫苗
Achilles Therapeutics Announces Research Collaboration With Arcturus Therapeuti...
05-22 19:00
Achilles Therapeutics Addresses Nasdaq Notice
Achilles Therapeutics Plc (ACHL) has released an update. Achilles Therapeutics ...
05-18 06:27
Achilles Therapeutics receives non-compliance notice from Nasdaq
Achilles Therapeutics (NASDAQ:ACHL) disclosed that the company received notice on May 16, 2024 from the Nasdaq that the company is not currently in compliance with minimum bid price requirement. The N...
05-18 05:34
Piper downgrades Achilles to neutral, cites latest data
Piper Sandler has downgraded Achilles Therapeutics (NASDAQ:ACHL) to neutral in the wake of additional Phase 1/2 data from its CHIRON and THETIS studies for its precision T cell therapy. Piper noted t...
04-05 22:44
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03.
04-05 02:39
BRNS, UPC and KWE among mid-day movers
Gainers: Allurion Technologies (ALUR) +107%. Candel Therapeutics (CADL) +93%. TC BioPharm plc (TCBP) +62%. HWH International (HWH) +47%. Barinthus Biotherapeutics Plc. (BRNS) +41%. Eiger BioPharmaceut...
04-05 01:06
Achilles Therapeutics GAAP EPS of -$0.46 misses by $0.32
Achilles Therapeutics press release (NASDAQ:ACHL): Q4 GAAP EPS of -$0.46 misses by $0.32. Cash and cash equivalents were $131.5 million as of December 31, 2023, as compared to $173.3 million as of Dec...
04-05 00:31
